Procalcitonin (CAS 56645-65-9) Market (Updated Version Available)

The report offers detailed coverage of Procalcitonin (CAS 56645-65-9) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Procalcitonin (CAS 56645-65-9) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.

The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.

The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.

The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.

There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.


The report forecast global Procalcitonin (CAS 56645-65-9) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Procalcitonin (CAS 56645-65-9) market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis


At the same time, we classify Procalcitonin (CAS 56645-65-9) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Procalcitonin Antigen
Procalcitonin Antibody
Market by Application
Medical Industry
Scientific Research

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Procalcitonin (CAS 56645-65-9) market for the forecast period 2021 - 2025?
• What are the driving forces in the Procalcitonin (CAS 56645-65-9) market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Procalcitonin (CAS 56645-65-9) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?